{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:29:01Z","timestamp":1786994941211,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"am","delay-in-days":311,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA023281"],"award-info":[{"award-number":["R01DA023281"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.neuropharm.2022.109045","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:10:32Z","timestamp":1648811432000},"page":"109045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["PPL-138 (BU10038): A bifunctional NOP\/mu partial agonist that reduces cocaine self-administration in rats"],"prefix":"10.1016","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8151-0579","authenticated-orcid":false,"given":"Andrea","family":"Cippitelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3756-0365","authenticated-orcid":false,"given":"Madeline","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Zribi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2330-3675","authenticated-orcid":false,"given":"Gerta","family":"Cami-Kobeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Husbands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Toll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuropharm.2022.109045_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12809","article-title":"Sex differences in cocaine self-administration behaviour under long access versus intermittent access conditions","volume":"25","author":"Algallal","year":"2020","journal-title":"Addiction Biol."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109045_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/adb.12629","article-title":"Revisiting long-access versus short-access cocaine self-administration in rats: intermittent intake promotes addiction symptoms independent of session length","volume":"24","author":"Allain","year":"2019","journal-title":"Addiction Biol."},{"issue":"3 Suppl. l","key":"10.1016\/j.neuropharm.2022.109045_bib3","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0376-8716(03)00099-1","article-title":"Principles of drug abuse liability assessment in laboratory animals","volume":"70","author":"Ator","year":"2003","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109045_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41386-018-0125-6","article-title":"Sex differences in neural mechanisms mediating reward and addiction","volume":"44","author":"Becker","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2022.109045_bib5","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1097\/j.pain.0000000000001318","article-title":"Influence of neuropathic pain on nicotinic acetylcholine receptor plasticity and behavioral responses to nicotine in rats","volume":"159","author":"Brunori","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2022.109045_bib6","series-title":"National Survey on Drug Use and Health: Detailed Tables","year":"2015"},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109045_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.444","article-title":"Synergistic interaction between the agonism of cebranopadol at nociceptin\/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model","volume":"6","author":"Christoph","year":"2018","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109045_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0091-3057(99)00174-4","article-title":"Gender differences in the reinforcing properties of morphine","volume":"65","author":"Cicero","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109045_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12844","article-title":"Potent and selective NOP receptor activation reduces cocaine self-administration in rats by lowering hedonic set point","volume":"25","author":"Cippitelli","year":"2020","journal-title":"Addiction Biol."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109045_bib10","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00213-018-4883-y","article-title":"Differential regulation of alcohol taking and seeking by antagonism at alpha4beta2 and alpha3beta4 nAChRs","volume":"235","author":"Cippitelli","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109045_bib11","doi-asserted-by":"crossref","first-page":"26594","DOI":"10.1038\/srep26594","article-title":"A key role for the N\/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration","volume":"6","author":"Cippitelli","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109045_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02244173","article-title":"Opiate antagonists reduce cocaine but not nicotine self-administration","volume":"104","author":"Corrigall","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109045_bib13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.pbb.2006.11.022","article-title":"Sex differences in locomotor effects of morphine in the rat","volume":"85","author":"Craft","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109045_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/pr.115.011668","article-title":"Evaluation of the \"pipeline\" for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory, and clinical trial research","volume":"68","author":"Czoty","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109045_bib15","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1476-5381.2011.01482.x","article-title":"Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons","volume":"165","author":"Dang","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109045_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1124\/jpet.117.241042","article-title":"Cebranopadol blocks the escalation of cocaine intake and conditioned reinstatement of cocaine seeking in rats","volume":"362","author":"de Guglielmo","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"37","key":"10.1016\/j.neuropharm.2022.109045_bib17","doi-asserted-by":"crossref","first-page":"E5511","DOI":"10.1073\/pnas.1605295113","article-title":"A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates","volume":"113","author":"Ding","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"456","key":"10.1016\/j.neuropharm.2022.109045_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3483","article-title":"A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates","volume":"10","author":"Ding","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2022.109045_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pnpbp.2018.01.002","article-title":"Modeling cocaine relapse in rodents: behavioral considerations and circuit mechanisms","volume":"87","author":"Farrell","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109045_bib20","first-page":"198","article-title":"Evaluation of a sustained-release formulation of buprenorphine for analgesia in rats","volume":"50","author":"Foley","year":"2011","journal-title":"J. Am. Assoc. Lab Anim. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109045_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00213-012-2949-9","article-title":"Attenuation of cocaine and heroin seeking by mu-opioid receptor antagonism","volume":"227","author":"Giuliano","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109045_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JCP.0000000000000995","article-title":"Assessment of the abuse potential of cebranopadol in nondependent recreational opioid users: a phase 1 randomized controlled study","volume":"39","author":"Gohler","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109045_bib23","series-title":"UpToDate","article-title":"Cocaine use disorder in adults: epidemiology, pharmacology, clinical manifestations, medical consequences, and diagnosis","author":"Gorelick","year":"2021"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109045_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration","volume":"199","author":"Haney","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109045_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2016.07.026","article-title":"Rearing environment differentially modulates cocaine self-administration after opioid pretreatment: a behavioral economic analysis","volume":"167","author":"Hofford","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"11","key":"10.1016\/j.neuropharm.2022.109045_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.biopsych.2018.07.022","article-title":"Increased number and activity of a lateral subpopulation of hypothalamic orexin\/hypocretin neurons underlies the expression of an addicted state in rats","volume":"85","author":"James","year":"2019","journal-title":"Biol. Psychiatr."},{"issue":"12","key":"10.1016\/j.neuropharm.2022.109045_bib27","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jamapsychiatry.2013.2295","article-title":"Topiramate for the treatment of cocaine addiction: a randomized clinical trial","volume":"70","author":"Johnson","year":"2013","journal-title":"JAMA Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109045_bib28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/adb.12513","article-title":"Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption","volume":"23","author":"Kallupi","year":"2018","journal-title":"Addiction Biol."},{"issue":"5","key":"10.1016\/j.neuropharm.2022.109045_bib29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11920-010-0143-5","article-title":"What's new in the treatment of cocaine addiction?","volume":"12","author":"Kampman","year":"2010","journal-title":"Curr. Psychiatr. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109045_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.neuropharm.2022.109045_bib31","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00213-019-5164-0","article-title":"The transition to cocaine addiction: the importance of pharmacokinetics for preclinical models","volume":"236","author":"Kawa","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"19\u201320","key":"10.1016\/j.neuropharm.2022.109045_bib32","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1007\/s00213-016-4393-8","article-title":"Less is more: prolonged intermittent access cocaine self-administration produces incentive-sensitization and addiction-like behavior","volume":"233","author":"Kawa","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"25","key":"10.1016\/j.neuropharm.2022.109045_bib33","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/jm990517p","article-title":"Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397)","volume":"42","author":"Kawamoto","year":"1999","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109045_bib34","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/j.bja.2018.10.065","article-title":"BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates","volume":"122","author":"Kiguchi","year":"2019","journal-title":"Br. J. Anaesth."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109045_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"issue":"8","key":"10.1016\/j.neuropharm.2022.109045_bib36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1517\/13543784.2014.915312","article-title":"Drugs currently in Phase II clinical trials for cocaine addiction","volume":"23","author":"Kim","year":"2014","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109045_bib37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3565(25)30726-3","article-title":"Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain","volume":"199","author":"Koe","year":"1976","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109045_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1037\/1064-1297.6.3.255","article-title":"Effects of amphetamine, butorphanol, and morphine pretreatment on the maintenance and reinstatement of cocaine-reinforced responding","volume":"6","author":"Lynch","year":"1998","journal-title":"Exp. Clin. Psychopharmacol"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109045_bib39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0091-3057(81)90180-5","article-title":"Buprenorphine self-administration by rhesus monkey","volume":"15","author":"Mello","year":"1981","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109045_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","article-title":"Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures","volume":"14","author":"Mello","year":"1996","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109045_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0306-4522(96)00322-3","article-title":"Intracerebroventricular orphanin FQ\/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats","volume":"75","author":"Murphy","year":"1996","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neuropharm.2022.109045_bib42","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1124\/jpet.300.3.1111","article-title":"Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy","volume":"300","author":"Negus","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109045_bib43","series-title":"National Institute on Drug Abuse. Overdose Death Rates","year":"2021"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109045_bib44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pbb.2004.03.018","article-title":"Sex differences in the escalation of intravenous cocaine intake following long- or short-access to cocaine self-administration","volume":"78","author":"Roth","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109045_bib45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00213-003-1643-3","article-title":"Central administration of nociceptin\/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice","volume":"172","author":"Sakoori","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109045_bib46","series-title":"Drug Abuse Warning Network, 2011","year":"2013"},{"key":"10.1016\/j.neuropharm.2022.109045_bib47","series-title":"Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48","year":"2014"},{"key":"10.1016\/j.neuropharm.2022.109045_bib48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2018.05.005","article-title":"Nociceptin\/orphanin FQ opioid peptide (NOP) receptor and micro-opioid peptide (MOP) receptors both contribute to the anti-hypersensitive effect of cebranopadol in a rat model of arthritic pain","volume":"832","author":"Schiene","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109045_bib49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fpsyt.2017.00234","article-title":"Cebranopadol, a mixed opioid agonist, reduces cocaine self-administration through nociceptin opioid and mu opioid receptors","volume":"8","author":"Shen","year":"2017","journal-title":"Front. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2022.109045_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1300\/J069v21n01_04","article-title":"A comparison of patterns of methamphetamine and cocaine use","volume":"21","author":"Simon","year":"2002","journal-title":"J. Addict. Dis."},{"issue":"6","key":"10.1016\/j.neuropharm.2022.109045_bib51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40263-021-00821-0","article-title":"The NOP receptor system in neurological and psychiatric disorders: discrepancies, peculiarities and clinical progress in developing targeted therapies","volume":"35","author":"Toll","year":"2021","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109045_bib52","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/npp.2014.188","article-title":"Compulsive-like responding for opioid analgesics in rats with extended access","volume":"40","author":"Wade","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2022.109045_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0091-3057(03)00087-X","article-title":"Beta-funaltrexamine affects cocaine self-administration in rats responding on a progressive ratio schedule of reinforcement","volume":"75","author":"Ward","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"146","key":"10.1016\/j.neuropharm.2022.109045_bib54","doi-asserted-by":"crossref","first-page":"146ra110","DOI":"10.1126\/scitranslmed.3003948","article-title":"A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence","volume":"4","author":"Wee","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2022.109045_bib55","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3389\/fpsyt.2018.00638","article-title":"The nociceptin receptor (NOP) agonist AT-312 blocks acquisition of morphine- and cocaine-induced conditioned place preference in mice","volume":"9","author":"Zaveri","year":"2018","journal-title":"Front. Psychiatr."},{"issue":"13","key":"10.1016\/j.neuropharm.2022.109045_bib56","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1038\/npp.2011.165","article-title":"Brain-cocaine concentrations determine the dose self-administered by rats on a novel behaviorally dependent dosing schedule","volume":"36","author":"Zimmer","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2022.109045_bib57","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/npp.2012.37","article-title":"The motivation to self-administer is increased after a history of spiking brain levels of cocaine","volume":"37","author":"Zimmer","year":"2012","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:18:12Z","timestamp":1758439092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":57,"alternative-id":["S0028390822001046"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109045","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPL-138 (BU10038): A bifunctional NOP\/mu partial agonist that reduces cocaine self-administration in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109045"}}